Significados de anti-tnf therapy en inglés

The pneumococcal vaccination strategy should be optimized for patients with CD on anti-TNF therapy.

Anti-TNF therapies appear to attenuate the injurious effects of TNF.

Anti-TNF therapy is associated with a significantly increased risk of developing hypertension in patients with RA.

Future studies are needed to evaluate pharmacogenetics as a predicting marker in anti-TNF therapy in sarcoidosis.

Methods: We performed a systematic literature review of studies investigating anti-TNF therapy, CD, and postoperative recurrence.

Similarly, anti-TNF therapy with infliximab is reported to be rapidly effective in inducing and maintaining remission.

Conclusions: Patients with CD on anti-TNF therapy are at significant risk of an inadequate response to PPSV23.

Thus, for patients with RA, anti-TNF therapies set a new standard for symptom control and joint protection.

We used linear regression analysis to identify factors associated significantly with level of ALP during anti-TNF therapy.

The use of concomitant immunosuppressant therapies may be useful to optimize pharmacokinetic parameters when initiating anti-TNF therapy.

Anti-TNF therapy is associated with reduced risk of surgery and appears to alter the natural history of this complication.

Aims: To evaluate the effect of anti-TNF therapy on the HRQoL of patients with CPF in daily clinical practice.

This study investigated drug survival and treatment response rates of patients with PsA undergoing second- and third-line anti-TNF therapy.

Numbers needed to treat were calculated to compare the effect size of anti-TNF therapy between the AS matrix subpopulations.

The combination of both factors induced decreased anti-TNF-a levels and a higher percentage of patients on intensified anti-TNF therapy.

We aimed to determine the effect of preoperative anti-TNF therapy on postoperative complications in IBD patients undergoing abdominal surgery.